ListedSMEPharmaceuticals & DrugsSPML

Speciality Medicines IPO

Speciality Medicines IPO is a sme IPO raising ₹29 Cr at ₹117 – ₹124 a share. It listed on 30 Mar 2026 and trades at ₹188 today, +51.6% against its issue price of ₹124. It was subscribed 0.00× in total.

124
Issue price
188
Price now
+51.6%
Since issue price
30 Mar 2026
Listed on
0.00×Subscribed (final) · all exchanges

No bids yet

populated partly populated we hold nothing here — the tab says why

How its cohort has done

54 SME issues listed in 2026 that we can price today. This is the group this issue belongs to.

+1.3%
Median return since issue price
46.3%
Now trading below their issue price

Neither figure is a forecast for this issue — they describe what happened to comparable issues. Full cohort analytics →

What we hold for this issue

Stated up front on every issue, so a sparse page reads as a fact about the source rather than a broken one.

Category split — who bidQIB, non-institutional and retail, with sub-splits
How demand built over timeOnly one reading so far; the series builds as bidding runs
Price-point demand curveLive only — NSE stops serving this once bidding closes
Lead managers and registrarNot published — smaller SME issues often name none
Official documents1 document
Performance since listingComputed from our own daily closes

What happens when

19 Mar 2026Pre-apply opens
20 Mar 2026Bidding opens
24 Mar 2026Bidding closes
27 Mar 2026Allotment finalised — you find out what you got
27 Mar 2026Money refunded to unsuccessful bidders
30 Mar 2026Shares list and start trading
5 May 2026UPI mandate expires

Track SPECIALITY MEDICINES LIMITED

Results, orders, board decisions and every other filing — summarised and sent to your WhatsApp the minute they are out.

Open the company page

Figures are as published by the exchanges and the issuer’s prospectus. MarketPing publishes facts, comparisons and history only — nothing here is a recommendation to apply to this issue, and we do not publish grey market premium.